Advertisement

Clinicopathological characteristics of diffuse large B-cell lymphoma involving small and large intestines: an analysis of 126 patients

  • Akiko Miyagi MaeshimaEmail author
  • Hirokazu Taniguchi
  • Yuta Ito
  • Shunsuke Hatta
  • Tomotaka Suzuki
  • Sayako Yuda
  • Shinichi Makita
  • Suguru Fukuhara
  • Wataru Munakata
  • Tatsuya Suzuki
  • Dai Maruyama
  • Koji Izutsu
Original Article

Abstract

We analyzed the clinicopathologic characteristics of 136 intestinal diffuse large B-cell lymphomas (DLBCLs) among 126 patients. The DLBCL sites were categorized as: duodenum (n = 23), ileocecal region (n = 63), other small intestine (n = 29), rectum (n = 7), and other large intestine (n = 14). Patients with DLBCLs of the ileocecal region or other small intestine frequently underwent surgery for ileus or perforations (P < 0.001), were predominantly male (P = 0.042), and had a higher incidence of limited-stage disease (P = 0.001), lower International Prognostic Index (P = 0.015), and lower incidence of lactate dehydrogenase elevation (P = 0.007) than those with DLBCLs of other regions. Half of the intestinal DLBCLs exhibited the germinal center B-cell phenotype. A low-grade B-cell lymphoma background was found in 21% of the cases; the prevalence was significantly lower in the ileocecal region (13%, P = 0.025), suggesting a higher incidence of de novo DLBCLs. Intestinal follicular lymphoma (FL) and mucosa-associated lymphoid tissue (MALT) lymphoma backgrounds were observed in 10% and 0% of the cases, respectively. Five percent (5/107) of intestinal DLBCL cases were Epstein–Barr virus-encoded RNA-1 positive. The clinicopathologic characteristics of the DLBCLs differed by region. Histologic transformation of intestinal FL was observed in around 10% of the intestinal DLBCL cases.

Keywords

Large B-cell lymphoma Non-Hodgkin Duodenum Intestines Pathology 

Notes

Acknowledgements

We would like to thank Ms. Miura, Ms. Kina, and Ms. Sakaguchi for their technical assistance.

Funding

This work was supported in part by the Japan Agency for Medical Research and Development Fund (18ck0106349h0002)

Compliance with ethical standards

Conflict of interest

There are no conflicts of interest.

References

  1. 1.
    Lightner AL, Shannon E, Gibbons MM, Russell MM. Primary gastrointestinal non-Hodgkin’s lymphoma of the small and large intestines: a systematic review. J Gastrointest Surg. 2016;20:827–39.CrossRefGoogle Scholar
  2. 2.
    Chuang SS, Ye H, Yang SF, Huang WT, Chen HK, Hsieh PP, et al. Perforation predicts poor prognosis in patients with primary intestinal diffuse large B-cell lymphoma. Histopathology. 2008;53:432–40.CrossRefGoogle Scholar
  3. 3.
    Lee J, Kim WS, Kim K, Ko YH, Kim JJ, Kim YH, et al. Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leuk Lymphoma. 2004;45:339–44.CrossRefGoogle Scholar
  4. 4.
    Jaffe ES, Harris NL, Swerdlow SH, Ott G, Nathwani BN, de Jong D, et al. Follicular lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2017. p. 266–77.Google Scholar
  5. 5.
    Mori M, Kobayashi Y, Maeshima AM, Gotoda T, Oda I, Kagami Y, et al. The indolent course and high incidence of t(14;18) in primary duodenal follicular lymphoma. Ann Oncol. 2010;21:1500–5.CrossRefGoogle Scholar
  6. 6.
    Schmatz AI, Streubel B, Kretschmer-Chott E, Püspök A, Jäger U, Mannhalter C, et al. Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol. 2011;29:1445–51.CrossRefGoogle Scholar
  7. 7.
    Takata K, Okada H, Ohmiya N, Nakamura S, Kitadai Y, Tari A, et al. Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity: a multicenter, retrospective analysis in Japan. Cancer Sci. 2011;102:1532–6.CrossRefGoogle Scholar
  8. 8.
    Kelley SR. Mucosa-associated lymphoid tissue (MALT) variant of primary rectal lymphoma: a review of the English literature. Int J Colorectal Dis. 2017;32:295–304.CrossRefGoogle Scholar
  9. 9.
    Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–82.CrossRefGoogle Scholar
  10. 10.
    Davies AJ, Rosenwald A, Wright G, Lee A, Last KW, Weisenburger DD, et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol. 2007;136:286–93.CrossRefGoogle Scholar
  11. 11.
    Maeshima AM, Omatsu M, Nomoto J, Maruyama D, Kim SW, Watanabe T, et al. Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses. Cancer Sci. 2008;99:1760–8.CrossRefGoogle Scholar
  12. 12.
    Maeshima AM, Taniguchi H, Toyoda K, Yamauchi N, Makita S, Fukuhara S, et al. Clinicopathologic features of histologic transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients. Br J Haematol. 2016;174:923–31.CrossRefGoogle Scholar
  13. 13.
    Yoshino T, Nakamura S, Matsuno Y, Ochiai A, Yokoi T, Kitadai Y, et al. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma. Cancer Sci. 2006;97:163–6.CrossRefGoogle Scholar
  14. 14.
    Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579–86.CrossRefGoogle Scholar
  15. 15.
    Gascoyne RD, Campo E, Jaffe ES, Chan WC, Chan JKC, Rosenwald A, et al. Diffuse large B-cell lymphoma, NOS. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2017. p. 291–7.Google Scholar
  16. 16.
    Gramlich TL, Petras RE. Small intestine. In: Mills SE, editor. Histology for pathologists. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 617.Google Scholar

Copyright information

© Japanese Society of Hematology 2019

Authors and Affiliations

  • Akiko Miyagi Maeshima
    • 1
    Email author
  • Hirokazu Taniguchi
    • 1
  • Yuta Ito
    • 2
  • Shunsuke Hatta
    • 2
  • Tomotaka Suzuki
    • 2
  • Sayako Yuda
    • 2
  • Shinichi Makita
    • 2
  • Suguru Fukuhara
    • 2
  • Wataru Munakata
    • 2
  • Tatsuya Suzuki
    • 2
  • Dai Maruyama
    • 2
  • Koji Izutsu
    • 2
  1. 1.Pathology DivisionNational Cancer Center HospitalTokyoJapan
  2. 2.Department of HematologyNational Cancer Center HospitalTokyoJapan

Personalised recommendations